Baseline and on-statin treatment lipoprotein(a) levels for predicting cardiovascular events in patients with familial hypercholesterolemia

Lipoprotein(a) [Lp(a)] has been considered as a causal risk factor for cardiovascular disease (CVD) in the general population and levels vary in different ethnicities. However, no systemic analysis is currently available regarding the relation of plasma Lp(a) levels to cardiovascular events (CVEs) in Chinese patients with heterozygous familial hypercholesterolemia (HeFH).

Source: Atherosclerosis - October 12, 2019 Category: Cardiology Authors: Ye-Xuan Cao, Jing-Lu Jin, Yuan-Lin Guo, Di Sun, Hui-Hui Liu, Na-Qiong Wu, Rui-Xia Xu, Cheng-Gang Zhu, Geng Liu, Qian Dong, Jing Sun, Jian-Jun Li Source Type: research